Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint InhibitionBarzin Y. Nabet, Maximilian Diehn, Mohammad Shahrokh Esfahani et al.|Cell|2020Cited by 360
Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK DependenceMoriah H. Nissan, David B. Solit, Christine A. Pratilas et al.|Cancer Research|2014Cited by 310
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancerDanish Memon, Matthew D. Hellmann, Mohamed Reda Keddar et al.|Cancer Cell|2024Cited by 177